Title : Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer.

Pub. Date : 2014 Jun 15

PMID : 24740322






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer. Niclosamide androgen receptor Homo sapiens
2 CONCLUSIONS: Niclosamide was identified as a novel inhibitor of AR variants. Niclosamide androgen receptor Homo sapiens
3 Our findings offer preclinical validation of niclosamide as a promising inhibitor of AR variants to treat, either alone or in combination with current antiandrogen therapies, patients with advanced prostate cancer, especially those resistant to enzalutamide. Niclosamide androgen receptor Homo sapiens